328.20
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $328.20, with a volume of 1.51M.
It is down -7.67% in the last 24 hours and down -3.59% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$355.48
Open:
$351.79
24h Volume:
1.51M
Relative Volume:
1.78
Market Cap:
$23.10B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
43.87
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
-8.39%
1M Performance:
-3.59%
6M Performance:
+38.68%
1Y Performance:
+17.59%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
328.20 | 23.10B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout | AI
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin - AD HOC NEWS
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV - MarketBeat
Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
West Pharmaceutical Services, Inc. (WPS) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (WPS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge - Quiver Quantitative
West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - Yahoo Finance
West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang
West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha
Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical: Q2 Earnings Snapshot - theheraldreview.com
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha
West Pharma Sees 3Q Net Sales $820M-$835M >WST - Moomoo
West Pharmaceutical Services Q2 Earnings Call Highlights - MarketBeat
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharma Sees 3Q Adj EPS $2.14-Adj EPS $2.24 >WST - Moomoo
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical (WST) Receives Strong Outlook Amidst Quarterly Performance - GuruFocus
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
West Pharmaceutical Services Inc 2Q 2026: Revenue $872.3M, EPS $2.15— 10-Q Summary - TradingView
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharma says sterile packaging upgrades fuel demand for high-value plastics - Plastics News
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ... - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Hig - GuruFocus
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView
West Pharmaceutical Services (WST) Reports Strong Q2 2026 Earnin - GuruFocus
West Pharma raises profit forecast on strong demand for injectable drug components - 1470 & 100.3 WMBD
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - Benzinga
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results - MarketBeat
West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Why is West Pharmaceutical Services stock surging today? - Investing.com
West Pharmaceutical Services (NYSE:WST) Hits New 12-Month High After Earnings Beat - MarketBeat
Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook - Investing.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
West Pharmaceutical Services Inc Stock (WST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Option Exercise |
83.47 |
2,817 |
235,135 |
19,645 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):